Ignite Creation Date:
2024-05-06 @ 7:23 PM
Last Modification Date:
2024-10-26 @ 3:06 PM
Study NCT ID:
NCT05995093
Status:
RECRUITING
Last Update Posted:
2023-10-24
First Post:
2023-08-06
Brief Title:
The Proactive Diagnostic Value of Hemostatic Biomarkers in Disseminated Intravascular Coagulation
Sponsor:
Qilu Hospital of Shandong University
Organization:
Qilu Hospital of Shandong University
Study Overview
Official Title:
The Proactive Diagnostic Value of Hemostatic Biomarkers in Disseminated Intravascular Coagulation
Status:
RECRUITING
Status Verified Date:
2023-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The project was undertaking by Qilu Hospital of Shandong University aiming to evaluate diagnostic performance of hemostatic biomarkers in disseminated intravascular coagulation
Detailed Description:
Disseminated intravascular coagulation DIC is a life-threatening condition with high mortality necessitating timely and accurate diagnosis for effective management However current diagnostic systems can not recognize DIC at its reversible phase causing suboptimal treatment outcomes Consequently the current diagnostic criteria for DIC lacks earlier laboratory indicators Therefore the investigators aimed to assess the diagnostic potential of selected hemostatic biomarkers including thrombin-antithrombin complex TAT soluble thrombomodulin sTM tissue plasminogen activator inhibitor complex tPAI-C α2-plasmin inhibitor plasmin complex PIC and anti-thrombin III ATIII in evaluating DIC allowing for proactive diagnosis before the disease progresses into its irreversible phase
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None